Current Issues in Inhibitor Surveillance


Year: 2016

Language: English

Author(s): World Federation of Hemophilia

View Online
Additional Information

Panel discussion: Current Issues in Inhibitor Surveillance, does collaborative data gathering hold the key?

With the exception of lack of access to care and treatment, inhibitors are recognized as the most serious challenge in hemophilia care. A multidisciplinary panel of international experts discusses what the WFH, regulators, pharmaceutical companies, physicians, and patients must do to address this issue.

The opinions expressed in this video are those of the individual panelists and not the official position of the World Federation of Hemophilia.